<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00926536</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-15849</org_study_id>
    <secondary_id>SU-05122009-2518</secondary_id>
    <secondary_id>HEP0020</secondary_id>
    <nct_id>NCT00926536</nct_id>
  </id_info>
  <brief_title>Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance</brief_title>
  <official_title>Impact of C-arm CT in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transhepatic Arterial Chemoembolization (TACE): Optimal Imaging Guidance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siemens Healthcare Diagnostics Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be enrolled based on presence of HCC and eligibility for TACE. They will be
      randomized to one of two arms for imaging navigation to the optimal catheter location for
      chemotherapy injection to treat the first (possibly sole) tumor target. The two arms will be:
      TACE using C-arm CT supplemented by DSA or DSA only (only DSA images will be used for
      navigation and tumor vessel tracking). Navigation to subsequent treatment targets in all
      patients will be done with fluoroscopy, CACT, and DSA, as is standard of care at Stanford
      University Medical Center, and is not part of the study. Vascular complexity, which affects
      navigation difficulty and thus the need for imaging, will be assessed separately for use in
      data analysis by two radiologists on a four-point scale.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We hope to learn more about the utility of C-arm CT in patients undergoing TACE for HCC. Data
      will be evaluated with regards to:

        1. Sensitivity and specificity to diagnose additional tumors and its impact on
           transplantation criteria.

        2. The ability to decrease procedural time by aiding navigation through complex arterial
           anatomy.

        3. Impact on radiation dose. Although the patient would receive the radiation during C-arm
           CT, overall the number of DSA angiograms and fluroscopy may decrease, potentially
           negating any effect of the additional dose from C-arm CT
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose Area Product (DAP)</measure>
    <time_frame>Duration of a TACE procedure, an average of 2 hours</time_frame>
    <description>Dose area product (DAP) is a measure of the entire amount of energy (radiation dose) delivered to the patient by the beam (indicator of stochastic dose)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative Dose (CD), a Measure of Radiation Dose</measure>
    <time_frame>Duration of a TACE procedure, an average of 2 hours</time_frame>
    <description>CD - a measurement of total radiation to the skin (measure of a deterministic dose)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Carcinoma, Hepatocellular</condition>
  <arm_group>
    <arm_group_label>C-arm CT + DSA as needed'</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the group of subjects randomized in this group, the image guidance component of the procedure will be conducted by the acquisition of 3D CT-like images during a trans-hepatic arterial injection of iodinated contrast agent for road mapping the tumor feeding vessels and supplemented by DSA as needed by the operating physician as imaging guidance for planning tumor(s) treatment approach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DSA only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the group of subjects randomized in this group, present standard of care, i.e DSA imaging only will be used by the operating physician to map out the tumor vessels and used for treatment approach. Additional 3D CT-like images will be obtained, but only used if the operator cannot perform adequate planning using DSA alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C-arm CT + DSA as needed</intervention_name>
    <description>C-arm CT images obtained and supplemented with DSA if needed</description>
    <arm_group_label>C-arm CT + DSA as needed'</arm_group_label>
    <other_name>x-ray image intensifier</other_name>
    <other_name>C-arm CT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DSA only</intervention_name>
    <description>DSA imaging only</description>
    <arm_group_label>DSA only</arm_group_label>
    <other_name>Standard of care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients must be affected by HCC

        Patients must be 18 years old or older

        Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the
        TACE procedure.

        Ability to understand and the willingness to sign a written informed consent document.

        Exclusion Criteria:

        Subjects under the age of 18

        Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Rebecca Fahrig</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nishita N. Kothary</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2009</study_first_submitted>
  <study_first_submitted_qc>June 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2009</study_first_posted>
  <results_first_submitted>December 4, 2014</results_first_submitted>
  <results_first_submitted_qc>March 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 4, 2016</results_first_posted>
  <last_update_submitted>March 10, 2016</last_update_submitted>
  <last_update_submitted_qc>March 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Nishita Kothary</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study was open from 01/13/2009 thru 10/13/2010. During this period, subjects with HCC who were scheduled to undergo TACE were approached for permission to participate in the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>C-arm CT +DSA as Needed</title>
          <description>C-arm CT in imaging guidance of TACE supplemented with DSA as needed for vessel tracking and navigation</description>
        </group>
        <group group_id="P2">
          <title>DSA Only</title>
          <description>Only Digital subtraction images used for vessel tracking and tumor navigation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Only patients completing the study are represented here. The three patients that were excluded by the physician is because the patients disease had progressed by the time of the study</population>
      <group_list>
        <group group_id="B1">
          <title>C-arm CT + DSA as Needed</title>
          <description>C-arm CT in imaging guidance of TACE supplemented by DSA as needed for vessel navigation and tracking</description>
        </group>
        <group group_id="B2">
          <title>DSA Only</title>
          <description>DSA images only used for vessel navigation and tracking</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Over 18 years old</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Dose Area Product (DAP)</title>
        <description>Dose area product (DAP) is a measure of the entire amount of energy (radiation dose) delivered to the patient by the beam (indicator of stochastic dose)</description>
        <time_frame>Duration of a TACE procedure, an average of 2 hours</time_frame>
        <population>DAP measured in both groups</population>
        <group_list>
          <group group_id="O1">
            <title>C-arm CT +DSA as Needed</title>
            <description>C-arm CT images used for navigational purposes supplemented by DSA if needed</description>
          </group>
          <group group_id="O2">
            <title>DSA Only</title>
            <description>Only DSA imaging used for navigational purposes</description>
          </group>
        </group_list>
        <measure>
          <title>Dose Area Product (DAP)</title>
          <description>Dose area product (DAP) is a measure of the entire amount of energy (radiation dose) delivered to the patient by the beam (indicator of stochastic dose)</description>
          <population>DAP measured in both groups</population>
          <units>Gy.cm2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="184.2" lower_limit="148.2" upper_limit="220.2"/>
                    <measurement group_id="O2" value="137.4" lower_limit="101.1" upper_limit="173.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <p_value_desc>Decrease in DAP in C-arm CT +DSA group when compared to DSA only</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>71.6</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Dose (CD), a Measure of Radiation Dose</title>
        <description>CD - a measurement of total radiation to the skin (measure of a deterministic dose)</description>
        <time_frame>Duration of a TACE procedure, an average of 2 hours</time_frame>
        <population>CD measured in both groups</population>
        <group_list>
          <group group_id="O1">
            <title>C-arm CT +DSA as Needed</title>
            <description>C-arm CT images used for navigational purposes supplemented by DSA if needed</description>
          </group>
          <group group_id="O2">
            <title>DSA Only</title>
            <description>Only DSA imaging used for navigational purposes</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Dose (CD), a Measure of Radiation Dose</title>
          <description>CD - a measurement of total radiation to the skin (measure of a deterministic dose)</description>
          <population>CD measured in both groups</population>
          <units>mGy</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="626.4" lower_limit="439.5" upper_limit="813.3"/>
                    <measurement group_id="O2" value="784.7" lower_limit="537.3" upper_limit="1032.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.017</p_value>
            <p_value_desc>Decrease in CD in C-arm CT +DSA group when compared to DSA only</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>158.3</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The duration of the procedure, since this was an imaging study. TACE procedures are an average of 2 hours.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>C-arm CT + DSA as Needed</title>
          <description>C-arm CT used for the purposes of navigation, supplemented by DSA if needed</description>
        </group>
        <group group_id="E2">
          <title>DSA Only</title>
          <description>DSA only used for navigation</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial Hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This is an imaging study looking at two different modalities of imaging. There is no long term follow up or A/Es associated with this type of a study</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Nishita Kothary</name_or_title>
      <organization>Stanford University</organization>
      <phone>6504986020</phone>
      <email>kothary@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

